Polaris™ Platform
Cataract Surgery
Key Facts
About Horizon Surgical Systems
Horizon Surgical Systems is a pre-revenue, private medical device company founded in 2018 and based in Fremont, California, with additional offices in Malibu and Santa Monica. The company is developing the Polaris™ platform, an investigational robotic-assisted surgical system for cataract surgery that combines microsurgical robotics, real-time 3D imaging/guidance, and machine learning. With leadership combining clinical (CEO Jean-Pierre Hubschman, MD) and engineering (CTO Jacob Rosen, PhD) expertise, and backing from a seasoned board, Horizon aims to address the growing demand for cataract surgery by improving consistency and accessibility. The technology is currently in the investigational stage, not yet FDA-approved, and has progressed from extensive preclinical testing into human studies.
View full company profileTherapeutic Areas
Other Cataract Surgery Drugs
| Drug | Company | Phase |
|---|---|---|
| OMIDRIA | Omeros | Marketed |
| ZEPTOLink IOL Positioning System | Centricity Vision | Commercial |
| Cataract Portfolio | BVI Medical | Commercial |
| JASPER™ Cataract Surgery System | ForSight Robotics | preclinical |
| NP-T Preloaded Toric IOL Injection System | Nidek | Launched (2024) |